ejection-fraction

Documents about ejection-fraction

• Matching Perfusion and Metabolic Activity in HFpEF#830102ClinicalTrials.gov
• Changes in Intrathoracic Impedance During Sacubitril/Valsartan Treatment#869142ClinicalTrials.gov
• Pacing for Heart Failure With Preserved Ejection Fraction#901965ClinicalTrials.gov
• Viral respiratory tract infections in heart failure: the FINEARTS-HF trial#202612HAL (France)
• Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design#226812HAL (France)
• THE RELATIONSHIP BETWEEN CARDIAC RESYNCHRONİZATION THERAPY RESPONSE IN HEART FAILURE PATIENTS AND YKL-40 LEVELS#891472ClinicalTrials.gov
• Long Term Metabolic Effects of Sacubitril/Valsartan in Non-Diabetic and Diabetic Patients With Heart Failure Reduced Ejection Fraction: A Real Life Study#254385IRIS
• CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis#832263ClinicalTrials.gov
• An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China#880007ClinicalTrials.gov
• Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial#907441ClinicalTrials.gov
• Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction#234550ClinicalTrials.gov
• Right Ventricular Function and Pulmonary Hypertension in HFpEF#272467ClinicalTrials.gov
• Training in HFpEF-PH#325192ClinicalTrials.gov
• Beta 3 Agonist Treatment in Heart Failure#837927ClinicalTrials.gov
• Heart Failure and a Preserved Ejection Fraction#844864ClinicalTrials.gov
• Post STEMI Echo Registry#862181ClinicalTrials.gov
• Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure#890681ClinicalTrials.gov
• Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)#916215ClinicalTrials.gov
• Dapagliflozin With or Without Spironolactone for HFpEF#969596ClinicalTrials.gov
• Diagnosing Heart Failure With Preserved Ejection Fraction in Patients With Unexplained Dyspnea (Diagnose-HFpEF)#1032273ClinicalTrials.gov
• EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease#968905ClinicalTrials.gov
• Table 1_Effects of statins on functional capacity and cardiac remodeling in patients with heart failure and preserved ejection fraction: a randomized open-label pilot trial.docx#361745Figshare
• A Parallel Study Evaluating the Effect of A-F Betafood® on Gallbladder and Liver Function.#908478ClinicalTrials.gov
• Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®#303644ClinicalTrials.gov
• The Effects of SGLTi on Diabetic Cardiomyopathy#332666ClinicalTrials.gov
• Real World Experience in Heart Failure With Reduced Ejection Fraction (HFrEF) Patients Treated With sAc/vaL.#471556ClinicalTrials.gov
• Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care#838291ClinicalTrials.gov
• Nationwide Registry of Patients With Heart Failure With Improved and Supranormal Ejection Fraction#844547ClinicalTrials.gov
• SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial#846430ClinicalTrials.gov
• Pilot Study on Withdrawal of Spironolactone Among Heart Failure With Improved Ejection Fraction#859552ClinicalTrials.gov
• The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)#884180ClinicalTrials.gov
• Correlation Between C-Reactive Protein And Left Ventricular Ejection Fraction InN Anterior ST Elevation Myocardial Infarction#930365Acta Interna: The Journal of Internal Medicine
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction#979128ClinicalTrials.gov
• Pilot Study of Endoscopic Sleeve Gastroplasty for Obese Patients With Heart Failure and Preserved Ejection Fraction#801543ClinicalTrials.gov
• The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients#141128ClinicalTrials.gov
• Anatomically Faithful but Temporally Blind: Auditing Attribution for Left-Ventricular Ejection-Fraction Estimation from Echocardiography#370371arXiv CS
• Multidimensional cardiac functional phenotyping beyond ejection fraction: a multimodality imaging framework for cardiovascular care.#392744NCBI PubMed Central
• Distinct Exercise Response Patterns in Patients With Heart Failure With Preserved Ejection Fraction.#458672NCBI PubMed Central
• Plasma Metabolite Associations with Incident Heart Failure with Reduced and Preserved Ejection Fraction#471397bioRxiv / medRxiv
• Medical nutrition therapy in incretin-treated obesity-related heart failure with preserved ejection fraction.#613518NCBI PubMed Central
• Role of Exercise in Diastolic Heart Failure#877739ClinicalTrials.gov
• PHARM Optimal-HF Pilot#903834ClinicalTrials.gov
• Respiratory Muscle Function in Heart Failure#909088ClinicalTrials.gov
• A Trial of CRD-4730 in HFrEF#913734ClinicalTrials.gov
• Angiotensin-converting enzyme inhibitors in female patients with diabetes mellitus in reduced ejection fraction heart failure#955685Koc University Digital Collections
• Finding Gab in the Treatment of Heart Failure in Assiut University Hospital#1007663ClinicalTrials.gov
• Treatment of HFpEF With Nitrate Supplement#1009129ClinicalTrials.gov
• Effects of Repletion of Sodium Chloride on Natriuresis, Blood Pressure, and Neurohormonal Activity in Patients With Chronic Heart Failure With Reduced Ejection Fraction#832717ClinicalTrials.gov
• Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control#1009706ClinicalTrials.gov
• Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction.#9359NCBI PubMed Central